Medical Report 0401A – 117/01/19

Market group: Trade Goods > Industrial Goods

Inventory group: Commodity > General

Market

View on:

Basic

Mass:: 1 kg
Packaged volume:: 0.1 m³
Portion size:: 1

Industry

Adam4Eve Material Influence

Type Info

Type ID:: 41028
Base price:: 30.00 ISK
Group ID:: General
Icon ID:: 1192
Market group ID:: Industrial Goods
Radius:: 1 m
Volume:: 0.1 m³
Reference Data:: View JSON
ESI:: View JSON
SDE:: View JSON

Description

>> DB AUTH 90104
>> SECURE ACCESS POINT BRAVO
>> PERSONNEL BLOCK – SUB LEVEL 12 – ROOM A113

>>ENTRY CLEARED

Subject shows no further signs of motion sickness or neural download corruption after ten seconds consciousness. Cognitive function reaches 99.7% within five seconds of awakening, spatial awareness confirmed with halo response test after five seconds of consciousness.

Treatment H22a appears to have resolved prior issues with lapse of cognitive function after neural re-alignment from quantum data transfer. Vital signs appear normal.

Given initial testing, will recommend to command that testing is expanded to whole of first subset, and subsequent batches of clones.

Currently awaiting approval from 6NJ for phase three testing. Kosakami and Laitanen seem preoccupied, may have to consult General Abraxas.

Report Ends.